67 related articles for article (PubMed ID: 18501538)
1. Physicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS process.
Kim JS; Kim MS; Park HJ; Jin SJ; Lee S; Hwang SJ
Int J Pharm; 2008 Jul; 359(1-2):211-9. PubMed ID: 18501538
[TBL] [Abstract][Full Text] [Related]
2. Modification of microenvironmental pH of nanoparticles for enhanced solubility and oral bioavailability of poorly water-soluble celecoxib.
Ran Woo M; Bak YW; Cheon S; Suk Kim J; Hun Ji S; Park S; Woo S; Oh Kim J; Giu Jin S; Choi HG
Int J Pharm; 2024 Apr; 659():124179. PubMed ID: 38692498
[TBL] [Abstract][Full Text] [Related]
3. PVP/aprepitant microcapsules produced by supercritical antisolvent process.
Zhang Z; Hao G; Sun X; Wang F; Zhang D; Hu D
Sci Rep; 2024 May; 14(1):10679. PubMed ID: 38724534
[TBL] [Abstract][Full Text] [Related]
4. Properties of Nanostructured Hydroxyapatite Prepared by a Spray Drying Technique.
Chow LC; Sun L; Hockey B
J Res Natl Inst Stand Technol; 2004; 109(6):543-51. PubMed ID: 27366633
[TBL] [Abstract][Full Text] [Related]
5. Development and Characterization of Pentaerythritol-EudragitRS100 Co-processed Excipients as Solid Dispersion Carriers for Enhanced Aqueous Solubility,
Telange DR; Bhaktani NM; Hemke AT; Pethe AM; Agrawal SS; Rarokar NR; Jain SP
ACS Omega; 2023 Jul; 8(28):25195-25208. PubMed ID: 37483203
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of Celecoxib-Eutectic Mixture Particles via Supercritical CO
Hong SH; Dinh L; Abuzar SM; Lee ES; Hwang SJ
Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 35893805
[TBL] [Abstract][Full Text] [Related]
7. Preparation and Characterization of Fenofibrate Microparticles with Surface-Active Additives: Application of a Supercritical Fluid-Assisted Spray-Drying Process.
Kim JS; Park H; Ha ES; Kang KT; Kim MS; Hwang SJ
Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959341
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies.
Bhujbal SV; Mitra B; Jain U; Gong Y; Agrawal A; Karki S; Taylor LS; Kumar S; Tony Zhou Q
Acta Pharm Sin B; 2021 Aug; 11(8):2505-2536. PubMed ID: 34522596
[TBL] [Abstract][Full Text] [Related]
9. Solubility Enhancement of Ibuprofen by Adsorption onto Spherical Porous Calcium Silicate.
Kawano Y; Chen S; Hanawa T
Pharmaceutics; 2021 May; 13(6):. PubMed ID: 34063903
[TBL] [Abstract][Full Text] [Related]
10. Polymers and Nanoparticles for Statin Delivery: Current Use and Future Perspectives in Cardiovascular Disease.
Nenna A; Nappi F; Larobina D; Verghi E; Chello M; Ambrosio L
Polymers (Basel); 2021 Feb; 13(5):. PubMed ID: 33652927
[TBL] [Abstract][Full Text] [Related]
11. The potential of Atorvastatin for chronic lung diseases therapy.
Tulbah AS
Saudi Pharm J; 2020 Nov; 28(11):1353-1363. PubMed ID: 33250642
[TBL] [Abstract][Full Text] [Related]
12. Combining Co-Amorphous-Based Spray Drying with Inert Carriers to Achieve Improved Bioavailability and Excellent Downstream Manufacturability.
Zhang Y; Gao Y; Du X; Guan R; He Z; Liu H
Pharmaceutics; 2020 Nov; 12(11):. PubMed ID: 33171591
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of dissolution of atorvastatin through preparation of polymeric solid dispersions using supercritical fluid technology.
Altaani B; Obaidat R; Malkawi W
Res Pharm Sci; 2020 Apr; 15(2):123-136. PubMed ID: 32582352
[TBL] [Abstract][Full Text] [Related]
14. The studies of PLGA nanoparticles loading atorvastatin calcium for oral administration
Li Z; Tao W; Zhang D; Wu C; Song B; Wang S; Wang T; Hu M; Liu X; Wang Y; Sun Y; Sun J
Asian J Pharm Sci; 2017 May; 12(3):285-291. PubMed ID: 32104340
[TBL] [Abstract][Full Text] [Related]
15. Fabrication of Supercritical Antisolvent (SAS) Process-Assisted Fisetin-Encapsulated Poly (Vinyl Pyrrolidone) (PVP) Nanocomposites for Improved Anticancer Therapy.
Chen LF; Xu PY; Fu CP; Kankala RK; Chen AZ; Wang SB
Nanomaterials (Basel); 2020 Feb; 10(2):. PubMed ID: 32070047
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of mesoporous SBA-15 and SBA-16 as carriers to improve albendazole dissolution rate.
Esperanza Adrover M; Pedernera M; Bonne M; Lebeau B; Bucalá V; Gallo L
Saudi Pharm J; 2020 Jan; 28(1):15-24. PubMed ID: 31920429
[TBL] [Abstract][Full Text] [Related]
17. Gel Formation Induced Slow Dissolution of Amorphous Indomethacin.
Heng W; Wei Y; Xue Y; Cheng H; Zhang L; Zhang J; Gao Y; Qian S
Pharm Res; 2019 Sep; 36(11):159. PubMed ID: 31515697
[TBL] [Abstract][Full Text] [Related]
18. Molecular Mobility and Stability Studies of Amorphous Imatinib Mesylate.
Karolewicz B; Górniak A; Marciniak DM; Mucha I
Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31266220
[TBL] [Abstract][Full Text] [Related]
19. Targeted delivery of atorvastatin via asialoglycoprotein receptor (ASGPR).
Zhang Y; Zhang X; Zeng C; Li B; Zhang C; Li W; Hou X; Dong Y
Bioorg Med Chem; 2019 Jun; 27(11):2187-2191. PubMed ID: 31005367
[TBL] [Abstract][Full Text] [Related]
20. Effects of Temperature and Ionic Strength of Dissolution Medium on the Gelation of Amorphous Lurasidone Hydrochloride.
Heng W; Wei Y; Zhou S; Ma D; Gao Y; Zhang J; Qian S
Pharm Res; 2019 Mar; 36(5):72. PubMed ID: 30915636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
